Nurse Practitioner in Darien, CT Accepting Medicare
5 Nurse Practitioner nurses found. Showing 1 - 5
 Ms. Zeenith Hyun Park, APRN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 688 Boston Post Rd, Darien, CT 06820 Phone: 203-662-9602 Fax: 203-662-0061 |
Jacklyn Truong, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 330 Boston Post Rd Ste 240, Darien, CT 06820 Phone: 203-548-7858 |
Kathleen S Africano, APRN Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 17 Old Kings Hwy S, Suite 1-2, Darien, CT 06820 Phone: 203-655-1559 |
Cassandra Shepard, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 30 Old Kings Hwy S, Darien, CT 06820 Phone: 203-883-0464 Fax: 203-883-0464 |
Meghan Maloney, AGPCNP-BC Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 36 Old Kings Hwy S Ste 200, Darien, CT 06820 Phone: 203-899-5027 Fax: 203-899-5027 |
News Archive
SkylineDx's MMprofiler receives CE-IVD certification
SkylineDx, today announced they have received CE-IVD registration from the European Competent Authority (Ministry of Health) for the MMprofiler, the company's prognostic test to determine the level of risk of a patient with multiple myeloma (MM).
Count those calories when you eat out because the chef won't!
According to a survey carried out in the U.S., counting how many calories are in the food they prepare is not something the average chef in a restaurant bothers about.
FDA files complaint against sandwich manufacturer; company allegedly failed to correct violations
The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against Rel's Foods Inc. (Rel's), of Oakland, Calif., seeking to stop the company from manufacturing, producing, and selling adulterated food products.
Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine
A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix.
Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.
› Verified 1 days ago